Selectis Health, Inc 8-K/A, filed Jan 3, 2022
Selectis Health, Inc. (GBCS)
About this 8-K/A
Selectis Health, Inc filed this 8-K/A on January 3, 2022, reporting on events of December 29, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter)
(State or other jurisdiction of incorporation) |
Commission File Number |
(I.R.S. Employer Identification number) |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s
telephone number, including area code:
(Former name or former address, if changed since last report)
| Written communications pursuant to Rule 425 under the Securities Act | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| ITEM 5.02 | RESCISSION OF COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS |
On December 30, 2021, Selectis Health, Inc., announced the grant of Restricted Stock Units (“RSU”) to certain of its officers. The RSU’s were issued under the Company’s 2021 Deferred Compensation and Equity Award Plan which was adopted effective July 1, 2021 (the “Plan”).
After further consideration, the Company and the grantees of such RSU’s, Lance Baller and Randy Barker, have agreed to rescind those grants.
| ITEM 9.01: | EXHIBITS |
| Item | Title | ||
| 4.4 | Rescission Agreement | ||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Selectis Health, Inc. | |
| (Registrant) | |
| Dated: January 03, 2022 | /s/ Lance Baller |
| Lance Baller, CEO |
Exhibit 4.4
